Showing 1 - 10 of 11,580
This article provides a tractable model of inter-temporal price-discrimination by heterogeneous firms, imperative for our understanding of advance purchase markets in the wake of entry. The pricing schedule of a more efficient entrant is found to differ systematically from the pricing schedule...
Persistent link: https://www.econbiz.de/10012548537
This paper investigates whether aggregate consumer learning together with consumer heterogeneity in price sensitivity could explain why (i) there is a slow diffusion of generic drugs into the market, and (ii) brand-name originators keep increasing their prices over time even after the number of...
Persistent link: https://www.econbiz.de/10014047796
mimics a reduction of switching costs and increases prices. While the effect of switching costs on prices in theory is …
Persistent link: https://www.econbiz.de/10012161505
mimics a reduction of switching costs and increases prices. While the effect of switching costs on prices in theory is …
Persistent link: https://www.econbiz.de/10014095430
Persistent link: https://www.econbiz.de/10012179614
This paper studies unshrouding decisions in a framework similar to Gabaix and Laibson (2006), but considers an alternative unshrouding mechanism where the impact of advertising add-on information depends on the number of unshrouding firms. We show that shrouding becomes less prevalent as the...
Persistent link: https://www.econbiz.de/10010223577
When products are sold in advance, i.e. prior to consumption, consumers trade off an early, uninformed purchase at a low price against a late, informed purchase at a high price. This paper considers the effect of market structure on the prevalence of advance selling. We show that in an...
Persistent link: https://www.econbiz.de/10011446893
Persistent link: https://www.econbiz.de/10011730245
Generic pharmaceuticals provide low-cost access to treatment. Despite their chemical equivalence to branded products …
Persistent link: https://www.econbiz.de/10012455020
Generic pharmaceuticals provide low-cost access to treatment. Despite their chemical equivalence to branded products …
Persistent link: https://www.econbiz.de/10012949948